Skip to content

Goodwill at other companies

Abbott logo
AbbottABT
$35.22B+50.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$48.56B+9.2%
Boston Scientific logo
Boston ScientificBSX
$18.54B+6.9%
AtriCure logo
AtriCureATRC
$234.78M0.0%
Medtronic logo
MedtronicMDT
$42.59B+2.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$503.43M+8.4%

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s goodwill?
Pulse Biosciences, Inc. (PLSE) reported goodwill of $2.79M in Q1 2026.
How has Pulse Biosciences, Inc.'s goodwill changed year-over-year?
Pulse Biosciences, Inc.'s goodwill decreased by 0.0% year-over-year, from $2.79M to $2.79M.
What is the long-term trend for Pulse Biosciences, Inc.'s goodwill?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s goodwill has grown at a 0.0% compound annual growth rate (CAGR), from $2.79M to $2.79M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.